Ever After Foods develops a proprietary B2B technology platform to produce cultivated meat with claimed unmatched cost‑efficient scalability. Leveraging Pluri’s patented 3D cell expansion technology, the company moved from a pilot announced last year to an advanced scalable production platform for muscle and fat tissues. The platform reportedly enables partners to reduce production costs by over 90% while increasing productivity. Ever After Foods’ bioreactors are said to yield up to six times more protein and 700 times more lipids per cell versus other cultivated‑meat platforms, improving nutritional and flavor value. Pluri extended Ever After Foods’ license to include cultivated fish, expanding the company’s addressable product set. The company is positioned as a technology enabler serving partners across the cultivated‑food value chain.

Total raised

$10M

Funding rounds

1

Latest round

Equity

Latest activity

Jun 2024